-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1312.pdf
October 01, 2014 - new and evolving
health care interventions that are purported to or may hold potential to diagnose, treat … orally, in four 300 mg tablets, once daily, for a week.9
Clinical trials: Using mifepristone to treat … mifepristone off label for treating PMD, even with its
ongoing study for the labeled indication to treat
-
effectivehealthcare.ahrq.gov/products/diabetic-neuropathy/research-2017
-
effectivehealthcare.ahrq.gov/sites/default/files/s16.pdf
October 01, 2007 - not
regularly ensured that control women were getting adequate
calcium and vitamin D.7
Intention-to-treat … When there is substantial
dropout or crossover, however, intention-to-treat can under-
estimate both … Adherence (for drugs)
Comparison
Placebo or usual care
Usual care or optimal care
Intention to treat … Glasziou and Irwig19 proposed individualizing treat-
ment decisions by combining estimates of relative … the risk of stroke in
our 60-year-old patient over 10 years (from 1.2% to 1%, or a
number needed to treat
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-pregnancy-postpartum_research-protocol.pdf
March 29, 2013 - There are
also a wide array of nonpharmacological interventions that can be used to treat depression … In babies born to women who become pregnant while taking medications to treat
Source: http://effectivehealthcare.ahrq.gov … analysis
are provided: type of statistical test used, numbers analyzed, and whether an intention-to-treat … Intention-to-treat results will be recorded if available.
D. … attrition, crossover, adherence, and contamination; loss to followup; and the use of
intention-to-treat
-
effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_2012-12-10.pdf
January 01, 2012 - new and evolving
health care interventions that are purported to or may hold potential to diagnose, treat … Deep brain stimulation (DBS), which has
become an accepted modality to treat some movement disorders … being administered orally,
in tablet form, once daily, for several days.
8
Using mifepristone to treat … scale] (responders, HDRS = 15.4
[+/-2.8]).”
21
According to Medtronic, patients who undergo DBS to treat
-
effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1312.pdf
December 01, 2013 - new and evolving
health care interventions that are purported to or may hold potential to diagnose, treat … ASDs) implies a lack of progress in basic understanding of these disorders and
how to diagnose and treat … One topic that emerged as having potential is use of off-label intranasal oxytocin to treat social
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1306.pdf
June 01, 2013 - new and evolving
health care interventions that are purported to or may hold potential to diagnose, treat … has not been evaluated for longer than 4 weeks in patients with
SBS.39 Teduglutide is intended to treat … FDA
approves Gattex to treat short bowel syndrome.
[internet]. Silver Spring (MD): U.S.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-update_clinician.pdf
January 01, 2016 - Therapies for Clinically Localized Prostate Cancer
Therapies for Clinically Localized Prostate Cancer
Background
A National Institutes of Health (NIH) panel that convened
in 2011 recommended that AS—a strategy with curative
intent that involves regular monitoring of PSA levels and
repeat biopsies—should be offer…
-
effectivehealthcare.ahrq.gov/sites/default/files/s23.pdf
October 01, 2007 - In the late 80s and
early 90s, frequency measures such as numbers needed to
treat (NNT) were introduced … The number needed to treat: a clinically useful
measure of treatment effect. … Decisions on drug therapies by numbers
needed to treat: a randomized trial. … A randomized comparison of
patients’ understanding of number needed to treat and other common
risk reduction
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1406.pdf
June 01, 2014 - new and evolving
health care interventions that are purported to or may hold potential to diagnose, treat … and delivered by any suitably
equipped health care center, and dozens of orthopedic centers that treat … Unmet need and health outcomes: Current OA therapies treat only the symptoms and do not
restore cartilage … already be demand for the procedure,
even though MSC injection is similar to other injections used to treat … Unmet need and health outcomes: Current therapies for OA treat only the symptoms and do
not restore
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-202-thermoplasty-comments.pdf
December 14, 2017 - General
Comments
I did notice that you did not include a calculation of a number
needed to treat … on a per-
protocol basis, but the results were not
significant when assessed in the
intention-to-treat … The posterior probability of
superiority for BT in the intention-to-treat
analysis was 96.0%, less … This
type of comparison, called intention-to-
treat, is considered preferable. … We would recommend contextualizing these adverse events
by highlighting the methods utilized to treat
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis_hi_impact.pdf
January 01, 2014 - new and
evolving health care interventions that are purported to or may hold potential to diagnose, treat … patients because it is expected to be prescribed more by specialists, yet primary
care physicians treat … , belimumab has a far less
developed record of safety and efficacy than first-line agents used to treat … Some experts also added that infusion therapy might be new to physicians who routinely treat
gout, … In general, the experts stated that MSC injection is similar to other injections used to treat OA,
-
effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_june_2012.pdf
January 01, 2012 - new and evolving
health care interventions that are purported to or may hold potential to diagnose, treat … Donepezil, rivastigmine, and galantamine
are approved by FDA to treat the symptoms of mild to moderate … AD, and memantine is approved to
treat the symptoms of moderate to severe AD.
32
None of these drugs … have a dramatic impact on the health care system,
especially because it would be the first agent to treat … tool=pubmed
10
therapeutic agents to the central nervous system
and treat neurodegenerative
-
effectivehealthcare.ahrq.gov/sites/default/files/s149.pdf
October 01, 2007 - essential to account parsimoniously for
patients’ longitudinal characteristics that lead to changes in treat … patients with an ICD-9 code of
250.xx (diabetes mellitus) or a prescription fill for a drug used
to treat … We wish to
compare outcomes among such possible longitudinal treat-
ments, for example, with z � 1, 1 … The second assumption,
already implicit in the notation Yi(z) above, is that the treat-
ment assignment … The expected outcome for a particular longitudinal treat-
ment can be calculated as an average of the
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/major-depressive-disorder_consumer.pdf
September 01, 2016 - There are many ways to treat depression. … You and your health care professional can decide what might
be best to treat your depression.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0655-131114.pdf
May 22, 2013 - girls, different age groups) that treat children and adolescents with DBDs.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0094_04-09-2009.pdf
January 01, 2009 - what is the comparative effectiveness of conducting a
comprehensive medical evaluation to detect and treat
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_surveillance.pdf
April 01, 2013 - CER #42:
Adjunctive Devices for Patients With Acute Coronary
Syndrome Undergoing Percutaneous Coronary
Intervention
Original release date:
December, 2011
Surveillance Report:
May, 2013
Key Findings:
- There have been relatively few new studies, and those that
have been published report results consi…
-
effectivehealthcare.ahrq.gov/products/diabetic-neuropathy
-
effectivehealthcare.ahrq.gov/sites/default/files/s96.pdf
October 01, 2007 - ORIGINAL ARTICLE
Evaluation and Overview of the National Electronic Injury
Surveillance System-Cooperative Adverse Drug Event
Surveillance Project (NEISS-CADES)
Michael A. Jhung, MD, MPH,* Daniel S. Budnitz, MD, MPH,* Aaron B. Mendelsohn, PhD,*†
Kelly N. Weidenbach, MPH,* Theresa D. Nelson, MS,‡ and Daniel A. Polloc…